Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens

American Journal of Kidney Diseases

Volumn 60, Issue 4, 2012, Pages 530-538

  Chen, Kuan Hsing ^a   Lin, Ja Liang ^a   Lin Tan, Dan Tzu ^a   Hsu, Hsiang Hao ^a   Hsu, Ching Wei ^a   Hsu, Kuang Hung ^b   Yen, Tzung Hai ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

body lead burden; Progressive diabetic nephropathy; repeated EDTA chelation therapy; type 2 diabetes

Indexed keywords

CREATININE; EDETATE CALCIUM DISODIUM; LEAD; PLACEBO;

ADULT; AGED; ARTICLE; CHELATION THERAPY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SINGLE BLIND PROCEDURE; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; AGED; CHELATING AGENTS; CHELATION THERAPY; CREATININE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EDETIC ACID; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LEAD; MALE; MIDDLE AGED;

EID: 84866357027     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.04.028     Document Type: Article

References (35)

1. J.A. Staessen, R.R. Lauwerys, J.-P. Buchet Impairment of renal function with increasing blood lead concentrations in the general population N Engl J Med 327 3 1992 151 156
2. R. Kim, A. Rotnitsky, D. Sparrow, S. Weiss, C. Wager, H. Hu A longitudinal study of low level lead exposure and impairment of renal function: the Normative Aging Study JAMA 275 15 1996 1177 1181
3. C.A. Pollock, L.S. Ibels Lead nephropathy - a preventable cause of renal failure Int J Artif Organs 11 2 1988 75 78
4. J.L. Lin, K.H. Yeh, H.C. Tseng, W.Y. Chen, H.H. Lai, Y.C. Lin Urinary N-acetyl-glucosaminidase excretion and environmental lead exposure Am J Nephrol 13 6 1993 442 447
5. J.L. Lin, H.H. Ho, C.C. Yu Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency: a randomized, controlled trial Ann Intern Med 130 1 1999 7 13
6. J.L. Lin, D.T. Tan, K.H. Hsu, C.C. Yu Environmental lead exposure and progressive renal insufficiency Arch Intern Med 161 2 2001 264 271
7. C.C. Yu, J.L. Lin, D.T. Lin-Tan Environmental exposure to lead and progression of chronic renal disease: a four-year prospective longitudinal study J Am Soc Nephrol 15 4 2004 1016 1022
8. J.L. Lin, D.T. Tan, H.H. Ho, C.C. Yu Environmental lead exposure and urate excretion in the general population Am J Med 113 7 2002 563 568
9. J.L. Lin, D.T. Lin-Tan, K.H. Hsu, C.C. Yu Environmental lead exposure and progression of chronic renal diseases in patients without diabetes N Engl J Med 348 4 2003 277 286
10. K.H. Yoon, J.H. Lee, J.W. Kim Epidemic obesity and type 2 diabetes in Asia Lancet 368 9548 2006 1681 1688
11. US Renal Data System International comparisons USRDS USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2007 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 239 254
12. US Renal Data System USRDS 1999 Annual Data Report 1999 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 25 38
13. S.W. Tsaih, S. Korrick, J. Schwartz Lead, diabetes, hypertension, and renal function: the Normative Aging Study Environ Health Perspect 112 11 2004 1178 1182
14. J.L. Lin, D.T. Lin-Tan, C.C. Yu, Y.Y. Huang, K.L. Li Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes Kidney Int 69 11 2006 2049 2056
15. A.S. Levey, J.P. Bosch, J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 6 1999 461 470
16. T.K. Leung, A.O. Luk, W.Y. So, M.K. Lo, J.C. Chan Development and validation of equations estimating glomerular filtration rates in Chinese patients with type 2 diabetes Kidney Int 77 8 2010 729 735
17. B. Burney, R. Kalaitzidis, G. Bakris Novel therapies of diabetic nephropathy Curr Opin Nephrol Hypertens 18 2 2009 107 111
18. B. Isaksson Urinary nitrogen output as a validity test in dietary surveys Am J Clin Nutr 33 1 1980 4 5
19. S.K. Gerard, H. Khayam-Bashi Characterization of creatinine error in ketotic patients: a prospective comparison of alkaline picrate methods with an enzymatic method Am J Clin Pathol 84 5 1985 659 664
20. D. Behringer, P. Craswell, C. Mohl, M. Stoeppler, E. Ritz Urinary lead excretion in uremic patients Nephron 42 4 1986 323 329
21. R.P. Wedeen, D.K. Mallick, V. Batuman Detection and treatment of occupational lead nephropathy Arch Intern Med 139 1 1979 53 57
22. F. Khalil-Manesh, H.C. Gonick, A. Cohen Experimental model of lead nephropathy II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA) Environ Res 58 1 1992 35 54
23. C. Foglieni, A. Fulgenzi, P. Ticozzi Protective effect of EDTA preadministration on renal ischemia BMC Nephrol 7 2006 5
24. A.I. Sanchez-Fructuoso, M. Cano, M. Arroyo, C. Fernandez, D. Prats, A. Barrientos Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning Am J Kidney Dis 40 1 2002 51 58
25. I. Hininger, R. Waters, M. Osman Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy Free Radic Biol Med 38 12 2005 1565 1570
26. C. Jacobsen, K. Hartvigsen, M.K. Thomsen Lipid oxidation in fish oil enriched mayonnaise: calcium disodium ethylenediaminetetraacetate, but not gallic acid, strongly inhibited oxidative deterioration J Agric Food Chem 49 2 2001 1009 1019
27. Y. Ding, N.D. Vaziri, H.C. Gonick Lead-induced hypertension II. Response to sequential infusions of l-arginine, superoxide dismutase, and nitroprusside Environ Res 76 2 1998 107 113
28. R.P. Wedeen, V. Batuman, E. Landy Safety of EDTA lead mobilization test Environ Res 30 1 1983 58 62
29. D.T. Lin-Tan, J.L. Lin, T.H. Yen, K.H. Chen, Y.L. Huang Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases Nephrol Dial Transplant 22 10 2007 2924 2931
30. J.L. Lin, D.T. Lin-Tan, Y.J. Li, K.H. Chen, Y.L. Huang Low-level environmental exposure to lead and progressive chronic kidney diseases Am J Med 119 8 2006 707.e1 707.e9
31. A.I. Sánchez-Fructuoso, J. Blanco, M. Cano Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate Am J Kidney Dis 40 1 2002 59 67
32. D.E. Stangle, D.R. Smith, S.A. Beaudin, M.S. Strawderman, D.A. Levitsky, B.J. Strupp Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure Environ Health Perspect 115 2 2007 201 209
33. F. Barbosa Jr, J.E. Tanus-Santos, R.F. Gerlach, P.J. Parsons A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs Environ Health Perspect 113 12 2005 1669 1674
34. G. Da Rin, G. Amici, G. Virga, C. Bardin, P. Calzavara, C. Bocci Correction of glucose concentration interference on Jaffé kinetic creatinine assay in peritoneal dialysis Am J Nephrol 15 6 1995 480 487
35. G.L. Myers, W.G. Miller, J. Coresh National Kidney Disease Education Program Laboratory Working Group Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program Clin Chem 52 1 2006 5 18